# Integrating Environmental Cues at the Maternal-Fetal Vascular Interface

> **NIH NIH R01** · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · 2021 · $496,689

## Abstract

2. SUMMARY
Most indicated preterm deliveries occur due to ischemic placental diseases such as preeclampsia (PE) and
intrauterine growth restriction (IUGR) (1-4). The maternal-fetal interface in these conditions is characterized by
a set of placental findings collectively referred to as maternal vascular malperfusion (MVM) (5-7). This typically
involves either impaired invasion and remodeling of maternal spiral arterioles, resulting in diminished placental
perfusion (5, 6, 8-17), and/or impaired villous development, compromising establishment of an efficient
maternal-fetal transport interface (5, 6, 18, 19). We and others have shown that environmental factors such as
oxygen tension can modulate placental development and contribute to ischemic placental disease processes
via modulation of Hypoxia-inducible Factor (HIF)-dependent gene expression (10, 20-31). An unparalleled
opportunity to study environmental effects on embryonic and placental development occurs during in vitro
fertilization (IVF). We have shown that IVF has significant effects on blastocyst gene expression, cell number,
potential for implantation, placental development, embryonic and placental growth velocity, and adult health
(32-42). Importantly, multiple large population-based studies now confirm that environmental manipulation
associated with IVF significantly increases PE risk and IUGR in humans (RR 2.5 fold) (43-49). Here, we
confirm these findings and demonstrate that development of the maternal-fetal transport interface is specifically
impaired following IVF in mice and humans, and provide evidence that altered HIF signaling may play a role.
Supporting this, we demonstrate increased Hif-2α mRNA but decreased activity in murine IVF conceptuses,
likely due to redox stress and impaired mitochondrial bioenergetics, along with subsequent defects in
trophoblast differentiation and development of the labyrinthine placenta. We further show that HIF-2α links
trophoblast metabolism and differentiation in ways that differ significantly from HIF-1α, and postulate that
metabolic reprogramming within the placenta, coupled with impaired transporter gene expression and
development of the maternal-fetal transport interface, contribute to fetal growth restriction and PE risk in this
setting. Consistent with this, we find that IVF status in human pregnancies is associated with impaired villous
development compromising the maternal-fetal transport interface, decreased HIF-2α and Glut-3 expression,
and increased PE risk. Based on these observations, we propose to further define HIF-1α and -2α dependent
effects on trophoblast differentiation, function and metabolism, how they are impacted by IVF status in rodent
models, and the extent to which they contribute to the pathogenesis of ischemic placental diseases in human
pregnancies conceived by IVF. The collective expertise of the investigators involved uniquely positions us to
advance our understanding of the environmental drivers and metabolic co...

## Key facts

- **NIH application ID:** 10142512
- **Project number:** 5R01HD072455-08
- **Recipient organization:** UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
- **Principal Investigator:** EMIN MALTEPE
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $496,689
- **Award type:** 5
- **Project period:** 2012-08-01 → 2024-04-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10142512

## Citation

> US National Institutes of Health, RePORTER application 10142512, Integrating Environmental Cues at the Maternal-Fetal Vascular Interface (5R01HD072455-08). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10142512. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*